| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.001 |